Brain scan and blood test study aims to predict stroke recovery

NCT ID NCT07611136

Recruiting now Knowledge-focused Sponsor: Johannes Dorst Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 180 adults with cerebral small vessel disease to see how their condition changes over time after a stroke. Researchers will use MRI scans and blood tests to track disease progression and look for links to thinking skills, daily function, and stroke recurrence. The goal is to better understand the disease and find new ways to monitor it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better predict how small vessel disease progresses after a stroke, potentially guiding future treatments.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve health. Results may not apply to all patients, and biomarkers may not reliably predict disease course.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOMARKERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cerebral Small Vessel Diseases ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIOMARKERS CEREBRAL SMALL VESSEL DISEASE STROKE STROKE RECURRENCE

Contacts and locations

Locations

University Hospital Ulm, Department of Neurology, Germany
RECRUITING

Ulm, Baden-Wurttemberg, 89081, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.